N/A
N=116
Mindfulness, Group Therapy and Psychosis; Training Decreases Anxiety and Depression
Psychosis
Bottom Line
View on ClinicalTrials.gov: NCT04711460 ↗Enrolled (actual)
116
Serious AEs
0.0%
Results posted
Feb 2024
Primary outcome: Primary: Change in Generalized Anxiety Disorder-7 Pre/Post Test at Week 5 — 4.68; 6.28; 3.96; 7.38 units on a scale — p=0.003
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Younger participants (Behavioral); Older participants (Behavioral); TAU (Behavioral); TAU + MIndfulness practice (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Minnesota
- Primary completion
- Aug 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Generalized Anxiety Disorder-7 Pre/Post Test at Week 5 |
4.68; 6.28; 3.96; 7.38 | 0.003 sig |
| PRIMARY Change in Patient Health Questionnaire-9 Score From Pre / Post-test at Week 5 |
6.68; 6.96; 3.96; 7.38 | 0.002 sig |
| SECONDARY CAGE-Adapted to Include Drug Use (CAGE-AID) |
32; 32; 26; 26 | — |
| SECONDARY The Columbia Suicide Severity Rating Scale (C-SSRS) |
32; 32; 26; 26 | — |
Summary
The objective of this non-randomized, within-group comparison was to evaluate the addition of mindfulness as a new technique in an outpatient group therapy program for participants diagnosed with a psychotic spectrum disorder, alongside of cognitive behavioral therapy.
Eligibility Criteria
Inclusion Criteria
- All Diagnostic Statistical Manual, Fifth edition, (DSM-5) diagnoses that included a psychosis spectrum disorder
Exclusion Criteria
- those lacking symptoms of psychosis
Data sourced from ClinicalTrials.gov (NCT04711460). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.